Cargando…
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
Immunotherapy treatments harnessing the immune system herald a new era of personalized medicine, offering considerable benefits for cancer patients. Over the past years, tumor neoantigens emerged as a rising star in immunotherapy. Neoantigens are tumor-specific antigens arising from somatic mutation...
Autores principales: | Liu, Zaoqu, Lv, Jinxiang, Dang, Qin, Liu, Long, Weng, Siyuan, Wang, Libo, Zhou, Zhaokai, Kong, Ying, Li, Huanyun, Han, Yilin, Han, Xinwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576504/ https://www.ncbi.nlm.nih.gov/pubmed/36263174 http://dx.doi.org/10.7150/ijbs.76281 |
Ejemplares similares
-
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
por: Liu, Zaoqu, et al.
Publicado: (2022) -
Biological and pharmacological roles of m(6)A modifications in cancer drug resistance
por: Liu, Zaoqu, et al.
Publicado: (2022) -
Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
por: Liu, Zaoqu, et al.
Publicado: (2022) -
Exploring the roles of intestinal flora in enhanced recovery after surgery
por: Liu, Zaoqu, et al.
Publicado: (2023) -
Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)